# Clinical Classification of MAFLD Based Liver Biopsy

> **NCT06795646** · — · NOT_YET_RECRUITING · sponsor: **Beijing Friendship Hospital** · enrollment: 2000 (estimated)

## Conditions studied

- Metabolic Dysfunction Associated Steatotic Liver Disease
- Metabolic Dysfunction-associated Steatohepatitis (MASH)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06795646
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-08
- **Primary completion:** 2028-12-31
- **Final completion:** 2038-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-02-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06795646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06795646, "Clinical Classification of MAFLD Based Liver Biopsy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06795646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*